5/10/2010. ISPOR Good Research Practices for Comparative Effectiveness Research: Indirect Treatment Comparisons Task Force
|
|
- Chad Fleming
- 5 years ago
- Views:
Transcription
1 ISPOR Good Research Practices for Comparative Effectiveness Research: Indirect Treatment Comparisons Task Force Presentation of Two Draft Reports 17 May 2010 ITC Task Force: Leadership Team Lieven Annemans PhD MSc Ghent University and Brussels University Task Force Chair Annabel Barrett BSc Eli Lilly and Co Ltd, Surrey, UK Cornelis Boersma PhD, MSc University of Groningen, the Netherlands Joseph C Cappelleri PhD, MPH Pfizer Inc, US Jon Clouse RPh MS United HealthCare, US Beth Devine PharmD, MBA, PhD University of Washington, US Mireya Diaz PhD Henry Ford Health Systems, US Rachael Fleurence, PhD United BioSource Corp, US Neal Hawkins PhD Oxford Outcomes Ltd, UK David C Hoaglin PhD United BioSource Corp, US Robbin Itzler PhD Merck Research Laboratories, US ITC Task Force: Leadership Team (cont) Jeroen Jansen PhD Mapi Values, US Kay M Larholt ScD Karen Lee MA Canadian Agency for Drugs and Technologies (CADTH), Canada David Scott MA Oxford Outcomes Ltd, UK David Thompson PhD I3 Innovus, US ITC Task Force: Objectives Develop recommendations for good research practices for indirect treatment comparisons (ITC) & mixed treatment comparisons (MTC) Prepare two manuscripts Guidance for consumers of ITC research (i.e., those who use ITC data for decision making) Guidance for producers of ITC research (i.e., those who conduct analyses to generate ITC data) Guidelines for Consumers of ITC Broad Objectives Provide background on ITC/MTC research Why are ITC/MTC studies conducted? What are evidence networks? Which methods apply to which circumstances? Provide guidance on how to be an informed consumer of ITC/MTC research What main features to look for in an ITC/MTC report? What are strengths & limitations of ITC/MTC methods? Guidelines for Producers of ITC Broad Objectives Provide an overview of evidence gathering strategies for ITC/MTC How to search the literature for evidence networks Provide an overview of current statistical methods for ITC/MTC Common vs. different baseline treatments Fixed- vs. random-effects models Frequentist vs. Bayesian approaches Meta-regression Provide guidance on good practices for conduct of ITC/MTC research 1
2 Authors (lead + alphabetical listing) Paper 1 Guidelines for Review of ITC Research Rachael Fleurence PhD (Lead Author) Annabel Barrett BSc Cornelis Boersma PhD, MSc Joseph Cappelleri PhD, MPH Beth Devine PharmD, MBA, PhD Mireya Diaz PhD Neal Hawkins PhD Robbin Itzler PhD Jeroen Jansen PhD Karen Lee MA Introduction Evidence networks Analyzing the evidence Underlying assumptions Statistical models Analytic frameworks Critically reviewing an ITC study report Internal validity External validity Reporting Interpreting ITC results Decision-making in the absence of RCTs Conclusion Appendix: Terminology section Introduction Given the evidence available, network meta-analysis (ITC/MTC) are often needed Head-to-head (direct) comparisons are unavailable or do not provide all the evidence available Network meta-analysis (ITC/MTC) are an extension of standard pairwise metaanalysis by including multiple pairwise comparisons across a range of interventions The goal of the Task Force is to provide guidance Networks of evidence Anchored ITC (or adjusted ITC) Network meta-analysis Closed loops in network: combination of direct and indirect evidence Mixed Treatment Comparison Validity of evidence synthesis relies on methods that appreciate within trial randomization; and limit bias due to lack of randomization across trials 2
3 Analyzing the evidence Heterogeneity variation in the same relative treatment effect between studies Similarity assumption If there is an imbalance in the distribution of effect modifiers (treatment x covariate interactions) between trials comparing different interventions then an ITC/MTC is biased. Evidence inconsistency discrepancy between different types of comparisons Comparisons A-B, B-C & A-C are consistent Consistency relates to the loops of evidence Analyzing the evidence Similarity assumption Consistency assumption A B C Direct comparison Indirect comparison Direct comparison A B C Indirect comparison Analyzing the evidence Statistical model choice Justification of models given evidence base endpoints, appreciation of randomization, heterogeneity, similarity/consistency Model critique / comparison of different models Analysis frameworks (Frequentist / Bayesian) The field is still in its infancy and methods are developing rapidly. Critically reviewing an ITC study - validity Internal validity Evidence base considered Bias in single trials Poor quality of individual trials Publication bias Are the outcomes, and statistical models appropriate given network of evidence? Bias due to similarity/consistency issues? External validity Source data RCTs designed for registration purposes with very homogenous population Critically reviewing an ITC study- Reporting Critically reviewing an ITC study- Reporting Introduction Clear statement of objective and rationale for comparisons and comparators Methods Literature review methods (PRISMA) Evidence network development Choice of models and exploration of model fit Results Source data from individual trials Model fit Base-case scenario (evidence base) Alternative scenarios Sensitivity analyses Discussion Critical assessment of the results with respect to internal validity (e.g. similarity/consistency) of ITC/MTC study Clinical and policy relevance Checklist in manuscript summarizes key issues regarding validity and reporting of ITC/MTC studies to assist decision-makers in evaluating the quality and relevance of a ITC/MTC (Note: checklist is not a validated instrument) 3
4 Interpreting an ITC study Are differences between treatments most likely true, or can they be explained away due to bias in the ITC/MTC To what extent are ITC/MTC results in line with expectations based on results of individual studies (and other evidence.) Do the results make sense from a biological / mode of action / clinical perspective? What do the results mean and what are implications for decision-making? Decision-making in the absence of ITC/MTC of RCTs Can we use evidence other than ITC/MTCs of RCTs for decision making? An ITC/MTC of RCTs is observational evidence, albeit with a greater internal validity than non-randomized comparative studies. Alternatively: What level of observational evidence can be considered to have sufficient internal validity to inform decision-making? Decision makers face trade off Risk of making the wrong decision by relying on lower quality evidence than (ITCs/MTCs of) RCTs, Postponing the decision by waiting for (ITC/MTCs of) RCTs, possibly forgoing health benefits Paper 2 Guidelines for Conduct of ITC Research Q & A Authors (lead + alphabetical listing) David C Hoaglin PhD (Lead Author) Annabel Barrett BSc Cornelis Boersma PhD, MSc Joseph C Cappelleri PhD, MPH Mireya Diaz PhD Neal Hawkins PhD Robbin Itzler PhD Jeroen Jansen PhD Kay M Larholt ScD David Scott MA David Thompson PhD Key Topics Evidence networks Statistical methods Assumptions Models Frequentist vs Bayesian approaches Checklist for good research practices Implementation Future research 4
5 Partial Overview Evidence Networks (1) All relevant treatments & trials comparing them directly Basic search standards from PRISMA Statement Assemble indirect comparators; shorter paths have more influence Some comparisons may have both indirect and direct evidence Evidence Networks (2) Totality of evidence? Can treatments not viewed as comparators contribute? Are higher-order indirect comparisons worth the effort? Start with comparators of interest. Iterate Capture relevant meta-analyses Statistical Methods, Assumptions (1) What are we trying to estimate? True effect of C relative to B (via A) d BC = μ C μ B = (μ C μ A ) (μ B μ A ) = d AC d AB Actual network arises because links not present are missing at random from network of all pairwise comparisons Statistical Methods, Assumptions (2) Variation in relative treatment effects Common effect: fixed-effects Distribution of effects: random-effects Similarity: distribution of treatment-effect modifiers must be similar across pairwise comparisons Consistency of indirect evidence with direct evidence (MTC) Checking may require statistical and clinical judgment Statistical Methods, Models (1) Measures of relative effect include Odds ratio ( responders ) Rate ratio ( events per person-year ) Risk ratio for having an event Risk ratio for not having an event Mean difference Hazard ratio ( survival ) Risk difference (often more difficult) Can present results in another scale 5
6 Statistical Methods, Models (2) Models for measures of relative effect Meta-analysis of AB trials Fixed-effects Random-effects Fixed-effects network meta-analysis (ITC or MTC) Random-effects network meta-analysis (ITC or MTC) Statistical Methods, Models (3) Meta-regression models may account for heterogeneity, minimize bias from violations of similarity/consistency, and improve prediction Approaches to capture impact of differences in study-level covariates Add constant treatment*covariate interactions Add treatment-specific treatment*covariate interactions Exchangeable treatment*covariate interactions Frequentist Statistical Methods Basis for traditional procedures Weighted means with confidence intervals (based on assumed normal distribution) Mantel-Haenszel estimate (a fixed-effects procedure) Maximum likelihood Bayesian Statistical Methods Likelihood relates data to parameters Prior distributions reflect initial uncertainty about the parameters ( integrate over) Vague (non-informative) Informative (e.g., from previous studies) Subject to sensitivity analysis Posterior distributions reflect uncertainty about parameters and other quantities, given the data (and the priors) Summarize posterior (e.g., mean, CrI) Can estimate ranking of treatments Good Research Practices Checklist Follow applicable parts of PRISMA Key components for ITC and MTC studies Objectives Search strategies Data collection Statistical analysis plan Data analysis Reporting Details in paper (also consumers checklist) Implementation Illustrative example of ITC and MTC Three treatments Several direct comparisons of each pair Fixed-effects meta-analysis (of OR) Random-effects meta-analysis Bayesian direct meta-analysis Bayesian ITC Bayesian MTC Details in appendix (including data and WinBUGS code) Software 6
7 Future Research (1) Methods for verifying similarity and consistency Empirical support for frequentist methods Methods to improve similarity of trials and empirical assessment of their benefit Individual patient data in ITC and MTC How to handle heterogeneity with small numbers of studies per intervention? Future Research (2) Multiple outcomes Place of ITC and MTC in hierarchy of study designs for strength of evidence Structure and properties of networks Size of network; evidence space versus decision space Q & A 7
Comparative Effectiveness Research Collaborative Initiative (CER-CI) PART 1: INTERPRETING OUTCOMES RESEARCH STUDIES FOR HEALTH CARE DECISION MAKERS
Comparative Effectiveness Research Collaborative Initiative (CER-CI) PART 1: INTERPRETING OUTCOMES RESEARCH STUDIES FOR HEALTH CARE DECISION MAKERS ASSESSING NETWORK META ANALYSIS STUDIES: A PROPOSED MEASUREMENT
More informationAgenda. Frequent Scenario WS I: Treatment Comparisons and Network Meta-Analysis: Learning the Basics
WS I: onducting & Interpreting Indirect Treatment omparisons and Network Meta-nalysis: Learning the asics onducted by members of the ISPOR Indirect Treatment omparisons Task Force Joe appelleri PhD MPH
More informationComparative Effectiveness Research Collaborative Initiative (CER-CI) PART 1: INTERPRETING OUTCOMES RESEARCH STUDIES FOR HEALTH CARE DECISION MAKERS
Comparative Effectiveness Research Collaborative Initiative (CER-CI) PART 1: INTERPRETING OUTCOMES RESEARCH STUDIES FOR HEALTH CARE DECISION MAKERS HEALTH EVIDENCE FOR DECISION MAKING: ASSESSMENT TOOL
More informationVALUE IN HEALTH 14 (2011) available at journal homepage:
VLUE IN HELTH 14 (2011) 417 428 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/jval SIENTIFI REPORT Interpreting Indirect Treatment omparisons and Network Meta-nalysis for
More informationNetwork Meta-Analysis for Comparative Effectiveness Research
Network Meta-Analysis for Comparative Effectiveness Research Joseph C. Cappelleri, Ph.D., M.P.H. Pfizer Inc Groton, CT e-mail:joseph.c.cappelleri@pfizer.com Oral presentation at the 19 th Annual Biopharmaceutical
More informationISPOR Task Force Report: ITC & NMA Study Questionnaire
INDIRECT TREATMENT COMPARISON / NETWORK META-ANALYSIS STUDY QUESTIONNAIRE TO ASSESS RELEVANCE AND CREDIBILITY TO INFORM HEALTHCARE DECISION-MAKING: AN ISPOR-AMCP-NPC GOOD PRACTICE TASK FORCE REPORT DRAFT
More informationHypothetical Scenario
Using Indirect and Multiple Treatment Comparisons Methods To Estimate Comparative Effectiveness of Alternative Treatments Workshop September 27, 2010 Beth Devine, PharmD, MBA, PhD Rafael Alfonso C., MD,
More informationComparing treatments evaluated in studies forming disconnected networks of evidence: A review of methods
Comparing treatments evaluated in studies forming disconnected networks of evidence: A review of methods John W Stevens Reader in Decision Science University of Sheffield EFPSI European Statistical Meeting
More information'Summary of findings' tables in network meta-analysis (NMA)
'Summary of findings' tables in network meta-analysis (NMA) Juan José Yepes-Nuñez MD, MSc, PhD candidate Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Canada Professor,
More informationGUIDELINE COMPARATORS & COMPARISONS:
GUIDELINE COMPARATORS & COMPARISONS: Direct and indirect comparisons Adapted version (2015) based on COMPARATORS & COMPARISONS: Direct and indirect comparisons - February 2013 The primary objective of
More informationUsing Statistical Principles to Implement FDA Guidance on Cardiovascular Risk Assessment for Diabetes Drugs
Using Statistical Principles to Implement FDA Guidance on Cardiovascular Risk Assessment for Diabetes Drugs David Manner, Brenda Crowe and Linda Shurzinske BASS XVI November 9-13, 2009 Acknowledgements
More informationEvidence-Based Medicine and Publication Bias Desmond Thompson Merck & Co.
Evidence-Based Medicine and Publication Bias Desmond Thompson Merck & Co. Meta-Analysis Defined A meta-analysis is: the statistical combination of two or more separate studies In other words: overview,
More informationInterpreting Prospective Studies
Comparative Effectiveness Research Collaborative Initiative (CER CI) PART 1: INTERPRETING OUTCOMES RESEARCH STUDIES FOR HEALTH CARE DECISION MAKERS ASSESSING PROSPECTIVE DATABASE STUDIES: A PROPOSED MEASUREMENT
More informationQuality and Reporting Characteristics of Network Meta-analyses: A Scoping Review
Quality and Reporting Characteristics of Network Meta-analyses: A Scoping Review Andrea C. Tricco MSc, PhD Scientist, Li Ka Shing Knowledge Institute of St. Michael s Hospital Assistant Professor, Dalla
More informationThe QUOROM Statement: revised recommendations for improving the quality of reports of systematic reviews
The QUOROM Statement: revised recommendations for improving the quality of reports of systematic reviews David Moher 1, Alessandro Liberati 2, Douglas G Altman 3, Jennifer Tetzlaff 1 for the QUOROM Group
More informationDevelopment of restricted mean survival time difference in network metaanalysis based on data from MACNPC update.
Development of restricted mean survival time difference in network metaanalysis based on data from MACNPC update. Claire Petit, Pierre Blanchard, Jean-Pierre Pignon, Béranger Lueza June 2017 CONTENTS Context...
More informationStatistical considerations in indirect comparisons and network meta-analysis
Statistical considerations in indirect comparisons and network meta-analysis Said Business School, Oxford, UK March 18-19, 2013 Cochrane Comparing Multiple Interventions Methods Group Oxford Training event,
More informationSeeing the Forest & Trees: novel analyses of complex interventions to guide health system decision making
Seeing the Forest & Trees: novel analyses of complex interventions to guide health system decision making Noah Ivers MD CCFP PhD Family Physician, Women s College Hospital Scientist, Women s College Research
More informationMeta-Analysis. Zifei Liu. Biological and Agricultural Engineering
Meta-Analysis Zifei Liu What is a meta-analysis; why perform a metaanalysis? How a meta-analysis work some basic concepts and principles Steps of Meta-analysis Cautions on meta-analysis 2 What is Meta-analysis
More informationMeta-analysis of safety thoughts from CIOMS X
CIOMS Working Group X Meta-analysis of safety thoughts from CIOMS X Stephen.Evans@Lshtm.ac.uk Improving health worldwide www.lshtm.ac.uk Evans: ENCePP CIOMS Meta Analysis 1 Acknowledgements, conflicts,
More informationResearch in Real-World Settings: PCORI s Model for Comparative Clinical Effectiveness Research
Research in Real-World Settings: PCORI s Model for Comparative Clinical Effectiveness Research David Hickam, MD, MPH Director, Clinical Effectiveness & Decision Science Program April 10, 2017 Welcome!
More informationSUMMARY OF perc DELIBERATIONS ON REQUEST FOR ADVICE
SUMMARY OF perc DELIBERATIONS ON REQUEST FOR ADVICE On March 7, 2013, perc issued a reimbursement recommendation for axitinib (Inlyta) for metastatic RCC. On April 18, 2017, the pcodr PAG submitted a Request
More informationBayesian approaches to analysing studies and summarizing evidences
Bruxelles, February 10, 2012 Bayesian approaches to analysing studies and summarizing evidences Paolo Bruzzi Clinical Epidemiology Unit National Cancer Research Institute Genova - Italy Conventional Statistical
More informationKristian Thorlund 1,2*, Zafar Zafari 3, Eric Druyts 4,5, Edward J Mills 1,5 and Mohsen Sadatsafavi 6
Thorlund et al. Cost Effectiveness and Resource Allocation 2014, 12:8 METHODOLOGY Open Access The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis - a case study of
More informationDRAFT (Final) Concept Paper On choosing appropriate estimands and defining sensitivity analyses in confirmatory clinical trials
DRAFT (Final) Concept Paper On choosing appropriate estimands and defining sensitivity analyses in confirmatory clinical trials EFSPI Comments Page General Priority (H/M/L) Comment The concept to develop
More informationEvaluating the Quality of Evidence from a Network Meta- Analysis
Evaluating the Quality of Evidence from a Network Meta- Analysis Georgia Salanti 1, Cinzia Del Giovane 2, Anna Chaimani 1, Deborah M. Caldwell 3, Julian P. T. Higgins 3,4 * 1 Department of Hygiene and
More informationAn Empirical Assessment of Bivariate Methods for Meta-analysis of Test Accuracy
Number XX An Empirical Assessment of Bivariate Methods for Meta-analysis of Test Accuracy Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 54 Gaither
More informationModels for potentially biased evidence in meta-analysis using empirically based priors
Models for potentially biased evidence in meta-analysis using empirically based priors Nicky Welton Thanks to: Tony Ades, John Carlin, Doug Altman, Jonathan Sterne, Ross Harris RSS Avon Local Group Meeting,
More informationTOOLS YOU CAN USE April 8, 2014
TOOLS YOU CAN USE April 8, 2014 Academy of Managed Care Pharmacy International Society for Pharmacoeconomics and Outcomes Research National Pharmaceutical Council Speakers Brian Sweet, MBA Executive Director,
More informationEvidence synthesis with limited studies
Evidence synthesis with limited studies Incorporating genuine prior information about between-study heterogeneity PSI conference 2018 Dr. Shijie (Kate) Ren, Research Fellow, School of Health and Related
More informationSimulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons
Song et al. BMC Medical Research Methodology 2012, 12:138 RESEARCH ARTICLE Open Access Simulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons Fujian Song
More informationSystematic review with multiple treatment comparison metaanalysis. on interventions for hepatic encephalopathy
Systematic review with multiple treatment comparison metaanalysis on interventions for hepatic encephalopathy Hepatic encephalopathy (HE) is a reversible neuropsychiatric syndrome associated with severe
More informationComparison of Meta-Analytic Results of Indirect, Direct, and Combined Comparisons of Drugs for Chronic Insomnia in Adults: A Case Study
ORIGINAL ARTICLE Comparison of Meta-Analytic Results of Indirect, Direct, and Combined Comparisons of Drugs for Chronic Insomnia in Adults: A Case Study Ben W. Vandermeer, BSc, MSc, Nina Buscemi, PhD,
More informationWhat is indirect comparison?
...? series New title Statistics Supported by sanofi-aventis What is indirect comparison? Fujian Song BMed MMed PhD Reader in Research Synthesis, Faculty of Health, University of East Anglia Indirect comparison
More informationOverview and Comparisons of Risk of Bias and Strength of Evidence Assessment Tools: Opportunities and Challenges of Application in Developing DRIs
Workshop on Guiding Principles for the Inclusion of Chronic Diseases Endpoints in Future Dietary Reference Intakes (DRIs) Overview and Comparisons of Risk of Bias and Strength of Evidence Assessment Tools:
More informationWorkshop 21: INDIRECT TREATMENT COMPARISONS: AN INTERACTIVE WORKSHOP ON CHOOSING THE RIGHT TOOL FOR THE AVAILABLE DATA
Workshop 21: INDIRECT TREATMENT COMPARISONS: AN INTERACTIVE WORKSHOP ON CHOOSING THE RIGHT TOOL FOR THE AVAILABLE DATA ISPOR Europe 2018 Barcelona, Spain Wednesday, 14 November 2018 15:00 16:00 ISPOR Statistical
More informationMethods Research Report. An Empirical Assessment of Bivariate Methods for Meta-Analysis of Test Accuracy
Methods Research Report An Empirical Assessment of Bivariate Methods for Meta-Analysis of Test Accuracy Methods Research Report An Empirical Assessment of Bivariate Methods for Meta-Analysis of Test Accuracy
More informationSystematic reviews and meta-analyses of observational studies (MOOSE): Checklist.
Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. MOOSE Checklist Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease:
More informationProject Funded under FP7 - HEALTH Grant Agreement no Funded under FP7 - HEALTH Grant Agreement no
Developing methods of HTA for medical devices: WP3 - Methods for comparative effectiveness research of medical devices Final Conference November, 13 th 2015 U. Siebert, P. Schnell-Inderst, C. Iglesias,
More informationFundamental Clinical Trial Design
Design, Monitoring, and Analysis of Clinical Trials Session 1 Overview and Introduction Overview Scott S. Emerson, M.D., Ph.D. Professor of Biostatistics, University of Washington February 17-19, 2003
More informationMethods for assessing consistency in Mixed Treatment Comparison Meta-analysis
Methods for assessing consistency in Mixed Treatment Comparison Meta-analysis Sofia Dias, NJ Welton, AE Ades RSS 2009, Edinburgh Department of Community Based Medicine Overview Mixed Treatment Comparison
More informationDraft Methods Report Number XX
Draft Methods Report Number XX Bayesian Approaches for Multiple Treatment Comparisons of Drugs for Urgency Urinary Incontinence are More Informative Than Traditional Frequentist Statistical Approaches
More informationHow do we combine two treatment arm trials with multiple arms trials in IPD metaanalysis? An Illustration with College Drinking Interventions
1/29 How do we combine two treatment arm trials with multiple arms trials in IPD metaanalysis? An Illustration with College Drinking Interventions David Huh, PhD 1, Eun-Young Mun, PhD 2, & David C. Atkins,
More informationMeta-analysis of two studies in the presence of heterogeneity with applications in rare diseases
Meta-analysis of two studies in the presence of heterogeneity with applications in rare diseases Christian Röver 1, Tim Friede 1, Simon Wandel 2 and Beat Neuenschwander 2 1 Department of Medical Statistics,
More informationSystematic reviews: From evidence to recommendation. Marcel Dijkers, PhD, FACRM Icahn School of Medicine at Mount Sinai
Systematic reviews: From evidence to recommendation Session 2 - June 18, 2014 Going beyond design, going beyond intervention: The American Academy of Neurology (AAN) Clinical Practice Guideline process
More informationAutomating network meta-analysis
Automating network meta-analysis Gert van Valkenhoef Department of Epidemiology, University Medical Center Groningen (NL), Faculty of Economics and Business, University of Groningen (NL) Health Economics
More informationUsing Indirect Comparisons to Support a Health Technology Assessment (HTA)
Using Indirect Comparisons to Support a Health Technology Assessment (HTA) Chrissie Fletcher Executive Director & Regional Head Global Biostatistical Science, Amgen Disclaimer The views expressed herein
More informationCritical appraisal: Systematic Review & Meta-analysis
Critical appraisal: Systematic Review & Meta-analysis Atiporn Ingsathit MD.PhD. Section for Clinical Epidemiology and biostatistics Faculty of Medicine Ramathibodi Hospital Mahidol University What is a
More informationEfficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: A study level and a patient level network meta-analysis
Cope et al. BMC Pulmonary Medicine 2012, 12:29 RESEARCH ARTICLE Open Access Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: A study level and a patient level network
More informationNetwork Meta-Analysis of the Efficacy of Acupuncture, Alpha-blockers and Antibiotics on
Network Meta-Analysis of the Efficacy of Acupuncture, Alpha-blockers and Antibiotics on Chronic Prostatitis/Chronic Pelvic Pain Syndrome Zongshi Qin, Jiani Wu, Jinhui Tian, Jing Zhou, Yali Liu, Zhishun
More informationADDING VALUE AND EXPERTISE FOR SUCCESSFUL MARKET ACCESS. Per Sørensen, Lundbeck A/S
ADDING VALUE AND EXPERTISE FOR SUCCESSFUL MARKET ACCESS Per Sørensen, Lundbeck A/S Market Access - price & reimbursement Situation today within psychiatric and neurological diseases Increased requirements
More informationErlotinib for the first-line treatment of EGFR-TK mutation positive non-small cell lung cancer
ERRATUM Erlotinib for the first-line treatment of EGFR-TK mutation positive non-small cell lung cancer This report was commissioned by the NIHR HTA Programme as project number 11/08 Completed 6 th January
More informationMethods for evidence synthesis in the case of very few studies. Guido Skipka IQWiG, Cologne, Germany
Methods for evidence synthesis in the case of very few studies Guido Skipka IQWiG, Cologne, Germany 17 September 2018 Cochrane Colloquium 2018, Edinburgh, Statistical Methods Group meeting, G. Skipka 2
More informationBayesian Adjustments for Misclassified Data. Lawrence Joseph
Bayesian Adjustments for Misclassified Data Lawrence Joseph Bayesian Adjustments for Misclassified Data Lawrence Joseph Marcel Behr, Patrick Bélisle, Sasha Bernatsky, Nandini Dendukuri, Theresa Gyorkos,
More informationPartitioned survival analysis for decision modelling in health care: a critical review
Partitioned survival analysis for decision modelling in health care: a critical review Marta Soares ISPOR, Glasgow 2017 Acknowledgements: Beth Woods, Eleftherios Sideris, Stephen Palmer (University of
More informationPopulation-adjusted treatment comparisons Overview and recommendations from the NICE Decision Support Unit
Population-adjusted treatment comparisons Overview and recommendations from the NICE Decision Support Unit David M Phillippo, University of Bristol 3 Available from www.nicedsu.org.uk Outline Background
More informationA Brief Introduction to Bayesian Statistics
A Brief Introduction to Statistics David Kaplan Department of Educational Psychology Methods for Social Policy Research and, Washington, DC 2017 1 / 37 The Reverend Thomas Bayes, 1701 1761 2 / 37 Pierre-Simon
More informationBayesian Adjustments for Misclassified Data. Lawrence Joseph
Bayesian Adjustments for Misclassified Data Lawrence Joseph Marcel Behr, Patrick Bélisle, Sasha Bernatsky, Nandini Dendukuri, Theresa Gyorkos, Martin Ladouceur, Elham Rahme, Kevin Schwartzman, Allison
More informationIndirect Treatment Comparison Without Network Meta-Analysis: Overview of Novel Techniques
Indirect Treatment Comparison Without Network Meta-Analysis: Overview of Novel Techniques K. Jack Ishak, PhD, Executive Director, Statistics and Senior Research Scientist BACKGROUND There is generally
More informationIndirect Comparisons: heroism or heresy. Neil Hawkins With acknowledgements to Sarah DeWilde
Indirect Comparisons: heroism or heresy Neil Hawkins With acknowledgements to Sarah DeWilde 1 Outline Brief introduction to indirect comparisons Two practical examples Heroism or Heresy? 2 A Taxonomy of
More informationWHAT TO DO IN ABSENCE OF HEAD TO HEAD CLINICAL TRIAL DATA. Lead the economic evaluation group at CHERE, University of Technology, Sydney
WHAT TO DO IN ABSENCE OF HEAD TO HEAD CLINICAL TRIAL DATA MIXED TREATMENT COMPARISON (MTC) Stephen Goodall, Associate Professor of Health Economics Centre for Health Economics Research and Evaluation,
More informationDiscussion Leaders. Workshop Outline. David J. Vanness, PhD. Ágnes Benedict, MA, MS. Background
Discussion Leaders David J. Vanness, PhD Assistant Professor, Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health Ágnes Benedict, MA, MS GENERALIZED EVIDENCE
More informationModelling heterogeneity variances in multiple treatment comparison meta-analysis Are informative priors the better solution?
Thorlund et al. BMC Medical Research Methodology 2013, 13:2 RESEARCH ARTICLE Open Access Modelling heterogeneity variances in multiple treatment comparison meta-analysis Are informative priors the better
More informationStatistical considerations in indirect comparisons and network meta-analysis
Statistical considerations in indirect comparisons and network meta-analysis Said Business School, Oxford, UK March 18-19, 2013 Cochrane Comparing Multiple Interventions Methods Group Oxford Training event,
More informationQuantitative summaries of treatment effect estimates obtained with network meta-analysis of survival curves to inform decision-making
Cope and Jansen BMC Medical Research Methodology 2013, 13:147 RESEARCH ARTICLE Open Access Quantitative summaries of treatment effect estimates obtained with network meta-analysis of survival curves to
More informationDealing with uncertainty in the economic evaluation of health care technologies
Dealing with uncertainty in the economic evaluation of health care technologies Susan Claire Griffin, MSc. This thesis was submitted for the qualification of PhD by publications at the University of York
More informationApplications of Bayesian methods in health technology assessment
Working Group "Bayes Methods" Göttingen, 06.12.2018 Applications of Bayesian methods in health technology assessment Ralf Bender Institute for Quality and Efficiency in Health Care (IQWiG), Germany Outline
More informationMay 31, Re: Submission of revised manuscript (BMJ R1) Dear Drs. Villanueva and Godlee
May 31, 2016 Re: Submission of revised manuscript (BMJ.2016.032755.R1) Dear Drs. Villanueva and Godlee We greatly appreciate the positive critique of the reviewers' and the Editors in response to our revised
More informationST440/550: Applied Bayesian Statistics. (10) Frequentist Properties of Bayesian Methods
(10) Frequentist Properties of Bayesian Methods Calibrated Bayes So far we have discussed Bayesian methods as being separate from the frequentist approach However, in many cases methods with frequentist
More informationApproaches to Integrating Evidence From Animal and Human Studies in Chemical Assessments
Approaches to Integrating Evidence From Animal and Human Studies in Chemical Assessments Kris Thayer, National Center for Environmental Assessment (NCEA) Integrated Risk Information System (IRIS) Division
More informationSubject: Canadian Diabetes Association Feedback on New Drugs for Type 2 Diabetes: Second-Line Therapy: A Therapeutic Review Update
February 3, 2017 Canadian Agency for Drugs and Technologies in Health (CADTH) 865 Carling Avenue, Suite 600 Ottawa, Ontario K1S 5S8 Subject: Canadian Diabetes Association Feedback on New Drugs for Type
More informationA Short Primer on Power Calculations for Meta-analysis
A Short Primer on Power Calculations for Meta-analysis Terri Pigott, Associate Provost for Research, Loyola University Chicago Editor, Methods Coordinating Group, Campbell Collaboration A webcast series
More informationBias-adjusted adjusted meta-analysis analysis of randomized and
Association of increased mortality with aprotinin administration in cardiac surgery? Bias-adjusted adjusted meta-analysis analysis of randomized and observational studies Society for Clinical Trials, 2011
More informationCochrane Pregnancy and Childbirth Group Methodological Guidelines
Cochrane Pregnancy and Childbirth Group Methodological Guidelines [Prepared by Simon Gates: July 2009, updated July 2012] These guidelines are intended to aid quality and consistency across the reviews
More informationStatistical considerations in indirect comparisons and network meta-analysis
Statistical considerations in indirect comparisons and network meta-analysis Said Business School, Oxford, UK March 18-19, 2013 Cochrane Comparing Multiple Interventions Methods Group Oxford Training event,
More informationWashington, DC, November 9, 2009 Institute of Medicine
Holger Schünemann, MD, PhD Chair, Department of Clinical Epidemiology & Biostatistics Michael Gent Chair in Healthcare Research McMaster University, Hamilton, Canada Washington, DC, November 9, 2009 Institute
More informationUniversity of Bristol - Explore Bristol Research
Mawdsley, D., Bennetts, M., Dias, S., Boucher, M., & Welton, N. (26). Model-Based Network Meta-Analysis: A Framework for Evidence Synthesis of Clinical Trial Data. CPT: Pharmacometrics and Systems Pharmacology,
More informationCurrent Issues with Meta-analysis in Medical Research
Current Issues with Meta-analysis in Medical Research Demissie Alemayehu Pfizer & Columbia Semanade Bioinformatica, Bioestadistica Analists de Supervivencia Instituto Panamericano de Estudios Avanzados
More informationHierarchical network meta-analysis models to address sparsity of events and differing treatment classifications with regard to adverse outcomes
Hierarchical network meta-analysis models to address sparsity of events and differing treatment classifications with regard to adverse outcomes Fiona C. Warren a*, Keith R. Abrams b, Alex J. Sutton b a
More informationManaged Care & Healthcare Communications, LLC. James T. Kenney, Jr, RPh, MBA
n reports n Managing the Evolving Complexity of Pharmacologic Treatment: Comparative Effectiveness Research, Pharmacoeconomic Data Analyses, and Other Decision Support Tools James T. Kenney, Jr, RPh, MBA
More informationStatistical considerations in indirect comparisons and network meta-analysis
Statistical considerations in indirect comparisons and network meta-analysis Said Business School, Oxford, UK March 18-19, 2013 Cochrane Comparing Multiple Interventions Methods Group Oxford Training event,
More informationAdvanced Issues in Multiple Treatment Comparison Meta-analysis
Advanced Issues in Multiple Treatment Comparison Meta-analysis Edward Mills PhD, MSc, MSt (1,2) Kristian Thorlund PhD, MStat (2) John Ioannidis MD, DSc (3) 1) Faculty of Health Sciences, University of
More informationCopyright GRADE ING THE QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS NANCY SANTESSO, RD, PHD
GRADE ING THE QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS NANCY SANTESSO, RD, PHD ASSISTANT PROFESSOR DEPARTMENT OF CLINICAL EPIDEMIOLOGY AND BIOSTATISTICS, MCMASTER UNIVERSITY Nancy Santesso,
More informationCOMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) POINTS TO CONSIDER ON MISSING DATA
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 15 November 2001 CPMP/EWP/1776/99 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) POINTS TO
More informationheterogeneity in meta-analysis stats methodologists meeting 3 September 2015
heterogeneity in meta-analysis stats methodologists meeting 3 September 2015 basic framework k experiments (i=1 k) each gives an estimate x i of θ, with variance s i 2 best overall estimate is weighted
More informationBayesian graphical models for combining multiple data sources, with applications in environmental epidemiology
Bayesian graphical models for combining multiple data sources, with applications in environmental epidemiology Sylvia Richardson 1 sylvia.richardson@imperial.co.uk Joint work with: Alexina Mason 1, Lawrence
More informationBayesian Multiparameter Evidence Synthesis to Inform Decision Making: A Case Study in Metastatic Hormone-Refractory Prostate Cancer
Original Manuscript Bayesian Multiparameter Evidence Synthesis to Inform Decision Making: A Case Study in Metastatic Hormone-Refractory Prostate Cancer Medical Decision Making 1 15 Ó The Author(s) 2018
More informationCARISMA-LMS Workshop on Statistics for Risk Analysis
Department of Mathematics CARISMA-LMS Workshop on Statistics for Risk Analysis Thursday 28 th May 2015 Location: Department of Mathematics, John Crank Building, Room JNCK128 (Campus map can be found at
More informationUniversity of Bristol - Explore Bristol Research. Publisher's PDF, also known as Version of record
Dias, S., Welton, NJ., Sutton, AJ., Caldwell, DM., Lu, G., & Ades, AE. (2011). NICE DSU Technical Support Document 4: Inconsistency in Networks of Evidence Based on Randomised Controlled Trials. (NICE
More informationFirst-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer: systematic review and network meta-analysis
Original Article First-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer: systematic review and network meta-analysis Lisa M. Hess, Amy M. DeLozier, Fanni Natanegara,
More informationIndex. Springer International Publishing Switzerland 2017 T.J. Cleophas, A.H. Zwinderman, Modern Meta-Analysis, DOI /
Index A Adjusted Heterogeneity without Overdispersion, 63 Agenda-driven bias, 40 Agenda-Driven Meta-Analyses, 306 307 Alternative Methods for diagnostic meta-analyses, 133 Antihypertensive effect of potassium,
More informationInformation Sharing Session on Rapid Review Initiatives. Chantelle Garritty Ottawa Methods Centre, Ottawa Hospital Research Institute (OHRI)
Information Sharing Session on Rapid Review Initiatives Chantelle Garritty Ottawa Methods Centre, Ottawa Hospital Research Institute (OHRI) Vancouver 2015 In the spirit of information sharing Asked to
More informationCADTH Optimal Use Report
Canadian Agency for Drugs and Technologies in Health Agence canadienne des médicaments et des technologies de la santé CADTH Optimal Use Report Volume 3, Issue 1B July 2013 Third-Line Pharmacotherapy for
More informationResearch Synthesis and meta-analysis: themes. Graham A. Colditz, MD, DrPH Method Tuuli, MD, MPH
Research Synthesis and meta-analysis: themes Graham A. Colditz, MD, DrPH Method Tuuli, MD, MPH Today Course format Goals, competencies Overview of themes for the class SRMA M19-551 Course Format Lectures»
More informationHistorical controls in clinical trials: the meta-analytic predictive approach applied to over-dispersed count data
Historical controls in clinical trials: the meta-analytic predictive approach applied to over-dispersed count data Sandro Gsteiger, Beat Neuenschwander, and Heinz Schmidli Novartis Pharma AG Bayes Pharma,
More informationImproved Transparency in Key Operational Decisions in Real World Evidence
PharmaSUG 2018 - Paper RW-06 Improved Transparency in Key Operational Decisions in Real World Evidence Rebecca Levin, Irene Cosmatos, Jamie Reifsnyder United BioSource Corp. ABSTRACT The joint International
More informationUniversity of Bristol - Explore Bristol Research. Publisher's PDF, also known as Version of record
Phillippo, D., Ades, T., Dias, S., Palmer, S., Abrams, K. R., & Welton, N. (2016). NICE DSU Technical Support Document 18: Methods for population-adjusted indirect comparisons in submissions to NICE. (Technical
More informationHeavy menstrual bleeding (update)
National Institute for Health and Care Excellence Draft Heavy menstrual bleeding (update) NICE guideline: methods NICE guideline TBC Methods August 0 Draft for Consultation Evidence reviews were developed
More informationRecent developments for combining evidence within evidence streams: bias-adjusted meta-analysis
EFSA/EBTC Colloquium, 25 October 2017 Recent developments for combining evidence within evidence streams: bias-adjusted meta-analysis Julian Higgins University of Bristol 1 Introduction to concepts Standard
More information